Humoral immune responses in gingival crevice fluid: local and systemic implications
2003; Wiley; Volume: 31; Issue: 1 Linguagem: Inglês
10.1034/j.1600-0757.2003.03109.x
ISSN1600-0757
Autores Tópico(s)Oral Health Pathology and Treatment
ResumoPeriodontology 2000Volume 31, Issue 1 p. 135-166 Humoral immune responses in gingival crevice fluid: local and systemic implications Jeffrey L. Ebersole, Jeffrey L. EbersoleSearch for more papers by this author Jeffrey L. Ebersole, Jeffrey L. EbersoleSearch for more papers by this author First published: 31 January 2003 https://doi.org/10.1034/j.1600-0757.2003.03109.xCitations: 119Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Adonogianaki E, Mooney J, Wennstrom JL, Lekholm U, Kinane DF. Acute-phase proteins and immunoglobulin G against P. gingivalis in peri-impant and crevicular fluid. Clin Oral Impl Res 1995: 6: 14 – 23. 2 Adonogianaki E, Moughal NA, Mooney J, Stirrups DR, Kinane DF. Acute-phase proteins in gingival crevicular fluid during experimentally induced gingivitis. J Periodontal Res 1994: 29: 196 – 202. 3 American Diabetes Association. Medical Management of Non-Insulin-Dependent (Type II) Diabetes. American Diabetes Association Clinical Education Series, 3rd edn. Alexandria, VA: American Diabetes Association, 1995. 4 Armitage GC. Development of a classification system for periodontal diseases and conditions. Ann Periodontol 1999: 4: 1 – 6. 5 Attstrom R, Laurell AB, Lahsson V, Sjoholm A. Complement factors in gingival crevice material from healthy and inflamed gingiva in humans. J Periodontal Res 1975: 10: 19 – 27. 6 Aukhil I, Lopatin DE, Syed SA, Morrison EC, Kowalski CJ. The effects of periodontal therapy on serum antibody (IgG) levels to plaque microorganisms. J Clin Periodontol 1988: 15: 544 – 550. 7 Baranowska HI, Palmer RM, Wilson RF. A comparison of antibody levels to Bacteroides gingivalis in serum and crevicular fluid from patients with untreated periodontitis. Oral Microbiol Immunol 1989: 4: 173 – 175. 8 Beck JD. Methods of assessing risk for periodontitis and developing multifactorial models. J Periodontol 1994: 65: 468 – 478. 9 Beck J, Garcia R, Heiss G, Vokonas PS, Offenbacher S. Periodontal disease and cardiovascular disease. J Periodontol 1996: 67: 1123 – 1137. 10 Bell GW, Large DM, Barclay SC. Oral health care in diabetes mellitus. Dent Update 1999: 26: 322 – 328. 11 Berglund SE. Immunoglobulins in human gingiva with specificity for oral bacteria. J Periodontol 1971: 42: 546 – 551. 12 Bergström J, Preber H. Tobacco use as a risk factor. J Periodontol 1994: 65: 545 – 550. 13 Bickel M. The role of interleukin-8 in inflammation and mechanisms of regulation. J Periodontol 1993: 64: 456 – 450. 14 Bimstein E, Ebersole JL. The age-dependent reaction of the periodontal tissues to dental plaque. ASDC J Dent Child 1989: 56: 358 – 362. 15 Bimstein E, Ebersole JL. Serum antibody levels to oral microorganisms in children and young adults with relation to the severity of gingival disease. Pediatr Dent 1991: 13: 267 – 272. 16 Bolstad AI, Kristoffersen T, Olsen I, Preus HR, Jensen HB, Vasstrand EN, Bakken V. Outer membrane proteins of Actinobacillus actinomycetemcomitans and Haemophilus aphrophilus studied by SDS-PAGE and immunoblotting. Oral Microbiol Immunol 1990: 5: 155 – 161. 17 Booth V, Ashley FB, Lehner T. Passive immunization with monoclonal antibodies against Porphyromonas gingivalis in patients with periodontitis. Infect Immun 1996: 64: 422 – 427. 18 Booth V, Lehner T. Characterization of the Porphyromonas gingivalis antigen recognized by a monoclonal antibody with prevents colonization by the organism. J Periodontal Res 1997: 32: 54 – 60. 19 Califano JV, Schenkein HA, Tew JG. Immunodominant antigens of Actinobacillus actinomycetemcomitans serotype b in early-onset periodontitis patients. Oral Microbiol Immunol 1992: 7: 65 – 70. 20 Challacombe SJ, Russell MW, Hawkes J. Passage of intact IgG from plasma to the oral cavity via crevicular fluid. Clin Exp Immunol 1978: 34: 417 – 422. 21 Challacombe SJ, Stephenson PA, Giel HM, Wilton JMA. Specific antibodies and opsonic activity in human crevicular fluid. Quantitation and relationships with disease. In: T Lehner, G Cimasoni, editors. The Borderland Between Caries and Periodontal Disease. Geneva: Editions Medicine et Hygiene, 1986: 87 – 103. 22 Chen HA, Johnson BD, Sims TJ, Darveau RP, Moncla BJ, Whitney CW, Engel D, Page RC. Humoral immune responses to Porphyromonas gingivalis before and following therapy in rapidly progressive periodontitis patients. J Periodontol 1991: 62: 781 – 791. 23 Christgau M, Palitzsch KD, Schmalz G, Kreiner U, Frenzel S. Healing response to non-surgical periodontal therapy in patients with diabetes mellitus: clinical, microbiological and immunologic results. J Clin Periodontol 1998: 25: 112 – 124. 24 Cimasoni G. Crevicular fluid updated. In: HM Myers, editor. Monographs in Oral Science. Basel: S. Karger, 1983: 45 – 102. 25 Collin HL, Uusitupa M, Niskanen L, Kontturi-Narhi V, Markkanen H, Loivisto AM, Heurman JH. Periodontal findings in elderly patients with non-insulin dependent diabetes mellitus. J Periodontol 1998: 69: 962 – 966. 26 Conderelli F, Scalia G, Cali G, Rossetti B, Nicoletti G, LoBue AM. Isolation of Porphyromonas gingivalis and detection of immunoglobulin A specific to fimbrial antigen in gingival crevicular fluid. J Clin Microbiol 1998: 36: 2322 – 2325. 27 Costerton JW, Lewandowski Z, Caldwell DE, Korber DR, Lappin-Scott HM. Microbial biofilms. Annu Rev Microbiol 1995: 49: 711 – 745. 28 Cutler CW, Eke P, Arnold RR, Van Dyke TE. Defective neutrophil function in an insulin-dependent diabetes mellitus patient. A case report. J Periodontol 1991: 62: 394 – 401. 29 Cutler CW, Machen RL, Jotwani R, Iacopino AM. Heightened gingival inflammation and attachment loss in type 2 diabetics with hyperlipidemia. J Periodontol 1999: 70: 1313 – 1321. 30 Damare SM, Wells S, Offenbacher S. Eicosanoids in periodontal diseases: potential for systemic involvement. Adv Exp Med Biol 1997: 433: 23 – 35. 31 Danielsen B, Wilton JMA, Baelum V, Johnson NW, Fejerskov O. Serum immunoglobulin G antibodies to Porphyromonas gingivalis. Prevotella intermedia, Fusobacterium nucleatum and Streptococcus sanguis during experimental gingivitis in young adults. Oral Microbiol Immunol 1993: 8: 154 – 160. 32 Darveau RP, Tanner A, Page RC. The microbial challenge in periodontitis. Periodontol 2000 1997: 14: 12 – 32. 33 Dasanayake AP. Periodontal disease as a risk factor in pregnancy. Ann Periodontol 1998: 3: 206 – 212. 34 Davenport ES, Williams CE, Sterne JA, Sivapathasundram V, Feran JM, Curtis MA. The East London Study of maternal chronic periodontal disease and preterm low birth weight infants: study design and prevalence data. Ann Periodontol 1998: 3: 213 – 221. 35 DeFronzo RA, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991: 14: 173 – 194. 36 DeRouen TA, Mancl L, Hujoel P. Measurement of associations in peirodontal diseases using statitistical methods for dependent data. J Periodontal Res 1991: 26: 218 – 229. 37 Destefano F, Anda RF, Kahn HS, Williamson DF, Russell CM. Dental disease and risk of coronary heart disease and mortality. Br Med J 1993: 306: 688 – 691. 38 Dibart S, Eftimiadi C, Socransky S, Taubman MA, Van Dyke TE. Rapid evaluation of serum and gingival crevicular fluid immunoglobulin G subclass antibody levels in patients with early-onset periodontitis using checkerboard immunoblotting. Oral Microbiol Immunol 1998: 13: 166 – 172. 39 Douvier S, Neuwirth C, Filipuzzi L, Kisterman JP. Chorioamnionitis with intact membranes caused by Capnocytophaga sputigena. Eur J Obstet Gynecol Reprod Biol 1999: 83: 109 – 112. 40 Drew WL. Epidemiology and prophylaxis of infectious diseases. In: KJ Ryan, editor. Medical Microbiology: an Introduction to Infectious Diseases. Norwalk, CN: Appleton & Lange, 1994: 179 – 188. 41 Dzink JL, Socransky SS, Haffajee AD. The predominant cultivable microbiota of active and inactive lesions of destructive periodontal diseases. J Clin Periodontol 1988: 15: 316 – 323. 42 Ebersole JL. Systemic humoral immune responses in periodontal disease. Crit Rev Oral Biol Med 1990: 1: 283 – 331. 43 Ebersole JL, Cappelli D. Gingival crevicular fluid antibody to A. actinomycetemcomitans in periodontal disease. Oral Microbiol Immunol 1994: 9: 335 – 344. 44 Ebersole JL, Cappelli D, Sandoval M-N. Subgingival distribution of A. actinomycetemcomitans in periodontitis. J Clin Periodontol 1994: 21: 65 – 75. 45 Ebersole JL, Cappelli D, Steffen MJ. Characteristics and utilization of antibody measurements in clinical studies of periodontal disease. J Periodontol 1992: 63: 1110 – 1116. 46 Ebersole JL, Cappelli D, Steffen MJ. Longitudinal dynamics of infection and serum antibody in A. actinomycetemcomitans periodontitis. Oral Dis 1995: 1: 129 – 138. 47 Ebersole JL, Cappelli D, Steffen MJ. Antigenic specificity of gingival crevicular fluid antibody to Actinobacillus actinomycetemcomitans. J Dent Res 2000: 79: 1362 – 1370. 48 Ebersole JL, Cappelli D, Steffen MJ, Willmann DE, O'Dell DS. Host response assessment in recurring periodontitis. J Clin Periodontol 1996: 23: 258 – 262. 49 Ebersole JL, Frey DE, Taubman MA, Smith DJ. IgG subclass antibody responses to periodontal microorganisms. J Dent Res 1985: 64: 197. 50 Ebersole JL, Frey DE, Taubman MA, Haffajee AD, Socransky SS. Dyamics of systemic antibody responses in periodontal disease. J Periodontal Res 1987: 22: 1. 51 Ebersole JL, Holt SC. Immunological procedures for diagnosis and risk assessment in periodontal diseases. In: L Dixon, editor. Periodontal Diseases. Markers of Disease Susceptibility and Activity. Cambridge: Cambridge University Press, 1991: 203 – 227. 52 Ebersole JL, Holt SC, Hansard R, Novak MJ. Periodontitis in Hispanics with non-insulin dependent diabetes mellitus. II. Laboratory Findings. J Periodontol submitted. 53 Ebersole JL, Sandoval M-N, Steffen MJ, Cappelli D. Serum antibody in A. actinomycetemcomitans-infected patients with periodontal disease. Infect Immun 1991: 59: 1795 – 1802. 54 Ebersole JL, Singer RE, Steffensen B, Filloon T, Kornman KS. Inflammatory mediators and immunoglobulins in GCF from healthy, gingivitis, and periodontitis sites. J Periodontal Res 1993: 28: 543 – 546. 55 Ebersole JL, Steffen MJ. Human antibody responses to outer envelope antigens of Porphyromonas gingivalis serotypes. J Periodontal Res 1995: 30: 1 – 14. 56 Ebersole JL, Taubman MA. The protective nature of host responses in periodontal diseases. Periodontol 2000 1994: 5: 112 – 141. 57 Ebersole JL, Taubman MA, Smith DJ. Local antibody responses in periodontal diseases. J Periodontol 1985: 56: 51 – 55. 58 Ebersole JL, Taubman MA, Smith DJ. Gingival crevicular fluid antibody to oral microorganisms. II. Distribution and specificity of local antibody responses. J Periodontal Res 1985: 20: 349 – 356. 59 Ebersole JL, Taubman MA, Smith DJ, Goodson JM. Gingival crevicular fluid antibody to oral microorganisms I. Method of collection and analysis of antibody. J Periodontal Res 1984: 19: 124 – 130. 60 Ebersole JL, Taubman MA, Smith DJ, Haffajee AD. Effect of subgingival scaling on systemic antibody responses to oral microorganisms. Infect Immun 1985: 48: 534 – 539. 61 Emrich LJ, Schlossman M, Genco RJ. Periodontal disease in non-insulin dependent diabetes mellitus. J Periodontol 1991: 62: 123 – 130. 62 Engstrom PE, Larsson A, Norhagen EG, Smith CIE, Sallberg M, Helgeland K, Hammarstrom L. Specificity and levels of oral and systemic antibodies to Actinobacillus actinomycetemcomitans. J Clin Periodontol 1993: 20: 746 – 751. 63 Ervasti T, Knuuttila M, Pohjamo L, Haukipuro K. Relation between control of diabetes and gingival bleeding. J Periodontol 1985: 56: 154 – 157. 64 Falkow S. Host-parasite relationships. In: KJ Ryan, editor. Medical Microbiology: an Introduction to Infectious Diseases. Norwalk, CN: Appleton & Lange, 1994: 141 – 168. 65 Farida R, Marsh PD, Newman HN, Rule DC, Ivanyi L. Serological investigation of various forms of inflammatory periodontitis. J Periodontal Res 1986: 21: 365 – 374. 66 Fives-Taylor P, Meyer D, Sreenivasan PK. Invasion of cultured epithelial cells by periodontopathogens. In: R Genco, S Hamada, T Lehner, JR McGhee, S Mergenhagen, editors. Molecular Pathogenesis of Periodontal Disease. Washington, DC: American Society for Microbiology, 1994: 57 – 68. 67 Fujihashi K, Kono Y, Beagley KW, Yamamoto M, McGhee JR, Mestecky J, Kiyono H. Cytokines and periodontal disease: immunopathological role of interleukins for B cell responses in chronic inflamed gingival tissues. J Periodontol 1993: 64: 400 – 406. 68 Fujihashi K, McGhee JR, Yamamoto M, Beagley KW, Kiyono H. Cytokine networks and immunoglobulin synthesis in inflamed gingival tissues. In: Genco R, Hamada S, Lehner T, McGhee JR, Mergenhagen S, editors. Molecular Pathogenesis of Periodontal Disease. Washington, DC: American Society for Microbiology, 1994: 135 – 145. 69 Galbraith GM, Hendley TM, Sanders JJ, Palesch Y, Pandey JP. Polymorphic cytokine genotypes as markers of disease severity in adult periodontitis. J Clin Periodontol 1999: 26: 705 – 709. 70 Garcia RI, Henshaw MM, Krall EA. Relationship between periodontal disease and systemic health. Periodontol 2000 2001: 25: 21 – 36. 71 Geivelis M, Turner DW, Pederson ED, Lamberts BL. Measurements of interleukin-6 in gingival crevicular fluid from adults with destructive periodontal disease. J Periodontol 1993: 64: 980 – 983. 72 Genco RJ. Assessment of risk of periodontal disease. Compend Contin Educ Dent 1994: 18: S678 – S683. 73 Genco RJ, Zambon JJ, Christersson LA. The role of specific bacteria in periodontal disease: The origin of periodontal infections. Adv Dent Res 1988: 2: 245 – 259. 74 Genco RJ, Zambon JJ, Murray PA. Serum and gingival fluid antibodies as adjuncts in the diagnosis of A. actinomycetemcomitans-associated periodontal disease. J Periodontol 1985: 56: 41 – 50. 75 Glurich I, Grossi S, Albini B, Ho A, Shah R, Zeid M, Baumann H, Genco RJ, DeNardin E. Systemic inflammation in cardiovascular and periodontal disease: comparative study. Clin Dign Lab Immunol 2002: 9: 425 – 432. 76 Govze Y, Herzberg MC. Serum and gingival crevicular fluid anti-desmosomal antibodies in periodontitis. J Periodontol 1993: 64: 603 – 608. 77 Grbic JT, Singer RE, Jans HH, Celenti RS, Lamster IB. Immunoglobulin isotypes in gingival crevicular fluid: possible protective role of IgA. J Periodontol 1995: 66: 55 – 61. 78 Grossi SG. Treatment of periodontal disease and control of diabetes: an assessment of the evidence and need for future research. Ann Periodontol 2001: 6: 138 – 145. 79 Grossi SG, Genco RJ. Periodontal disease and diabetes mellitus: a two-way relationship. Ann Periodontol 1998: 3: 51 – 61. 80 Grossi SG, Skrepcinski FB, DeCaro T, Robertson DC, Ho AW, Dunford RG, Genco RJ Treatment of periodontal disease in diabetics reduces glycated hemoglobin. J Periodontol 1997: 68: 713 – 719. 81 Grossi SG, Zambon JJ, Ho AW, Koch G, Dunford RG, Machtei EE, Norderyd OM, Genco RJ. Assessment of risk for periodontal disease. I. Risk indicators for attachment loss. J Periodontol 1994: 65: 260 – 267. 82 Gunsolley JC, Burmeister JA, Tew JG, Best A, Ranney RR. Relationship of serum antibody to attachment level patterns in young adults with juvenile periodontitis or generalized severe periodontitis. J Periodontol 1987: 58: 314 – 320. 83 Haber J, Wattles J, Crowley M, Mandell R, Joshipura K, Kent RL. Evidence for cigarette smoking as a major risk factor in periodontitis. J Periodontol 1993: 64: 16 – 23. 84 Haffajee AD, Socransky SS. Microbial etiological agents of destructive periodontal diseases. Periodontol 2000 1994: 5: 78 – 111. 85 Haffajee AD, Socransky SS, Goodson JM. Clinical parameters as predictors of destructive periodontal disease activity. J Clin Periodontol 1983: 10: 257 – 265. 86 Haffner SM, Stern M, Mitchell BD, Hazuda HP, Patterson JK. Incidence of type II diabetes in Mexican Americans predicted by fasting insulin and glucose levels, obesity, and body-fat distribution. Diabetes 1990: 39: 283 – 288. 87 Hall ER, Falkler WA, Martin SA, Suzuki JB. The gingival immune response to Actinobacillus actinomycetemcomitans in juvenile periodontitis. J Periodontol 1991: 62: 792 – 798. 88 Hall ER, Martin SA, Suzuki JB, Falkler WA Jr. The gingival immune response to periodontal pathogens in juvenile periodontitis. Oral Microbiol Immunol 1994: 9: 327 – 334. 89 Hammarstrom, CIE. Smith. IgG subclasses in bacterial infections. Monogr Allergy 1986: 19: 122. 90 Haraszthy VI, Zambon JJ, Trevisan M, Zeid M, Genco RJ. Identification of periodontal pathogens in atheromatous plaques. J Periodontol 2000: 7: 1554 – 1560. 91 Hernichel-Gorbach E, Kornman KS, Holt SC, Nichols F, Meador H, Kung JT, Thomas CA. Host responses in patients with generalized refractory periodontitis. J Periodontol 1994: 65: 8 – 16. 92 Hill GB. Preterm birth: associations with genital and possibly oral microflora. Ann Periodontol 1998: 3: 222 – 232. 93 Hillier SL, Nugent RP, Eschenbach DA, Krohn MA, Gibbs RS, Martin DH, Cotch MF, Edelman R, Pastorek JG, Rao AV, et al. Association between bacterial vaginosis and preterm delivery of a low birth-weight infant. N Engl J Med 1995: 333: 1737 – 1742. 94 Holbrook WP, Mooney J, Sigurdsson T, Kitsiou N, Kinane DF. Putative periodontal pathogens, antibody titres and avidities to them in a longitudinal study of patients with resistant periodontitis. Oral Dis 1996: 2: 217 – 223. 95 Hollister MC, Weintraub JA. The association of oral status with systemic health, quality of life, and economic productivity. J Dent Educ 1993: 57: 901 – 912. 96 Holmberg K, Killander J. Quantitative determination of immunoglobulins (IgG, IgA and IgM) and identification of IgA-type in the gingival fluid. J Periodontal Res 1971: 6: 1 – 8. 97 Honig J, Rordorf AC, Siegmund C, Wiedemann W, Erard K. Increased IL-1β concentration in gingival tissues of periodontitis patients. J Periodontal Res 1989: 24: 362 – 367. 98 Horibe M, Watanabe H, Ishikawa I. Effect of periodontal treatments on serum IgG antibody titers against periodontopathic bacteria. J Clin Periodontol 1995: 22: 510 – 515. 99 Jansen HJ, Van Der Hoeven JS, Van Den Kieboom CW, Goertz JH, Camp PJ, Bakkaren JA. Degradation of immunoglobulin G by periodontal bacteria. Oral Microbiol Immunol 1994: 9: 345 – 351. 100 Jeffcoat MJ, Geurs NC, Reddy MS, Cliver SP, Goldenberg RL, Hauth JC. Periodontal infection and preterm birth: Results of a prospective study. J Am Dent Assoc 2001: 132: 875 – 880. 101 Johannessen AC, Nilesen R, Kristoffersen T, Knudsen GE. Variation in the composition of gingival inflammatory cell infiltrates. J Clin Periodontol 1990: 17: 298 – 305. 102 Johnson NW, Griffiths GS, Wilton JM, Maiden MF, Curtis MA, Gillett IR, Wilson DT, Sterne JA. Detection of high-risk groups and individuals for periodontal diseases. Evidence for the existence of high-risk groups and individuals and approaches to their detection. J Clin Periodontol 1988: 15: 276 – 282. 103 Johnson V, Johnson BD, Sims TJ, Whitney CW, Moncla BJ, Engel LD, Page RC. Effects of treatment on antibody titer to Porphyromonas gingivalis in gingival crevicular fluid of patients with rapidly progressive periodontitis. J Periodontol 1993: 64: 566 – 570. 104 Joshipura KJ, Rimm EB, Douglass CW, Trichopoulos D, Ascherio A, Willett WC. Poor oral health and coronary heart disease. J Dent Res 1996: 75: 1631 – 1636. 105 Jotwani R, Palucka AK, Al-Quotub M, Nouri-Shirazi M, Kim J, Bell D, Banchereau J, Cutler C. Mature dendritic cells infiltrate the T cell-rich region of oral mucosa in chronic periodontitis: in situ, in vivo, and in vitro studies. J Immunol 2001: 167: 4693 – 4700. 106 Karimzadeh K, Morrison J, Zadeh HH. Comparison of gingival and peripheral blood T cells among patients with periodontitis suggests skewing of the gingival T cell antigen receptor V beta repertoire. J Periodontal Res 1999: 34: 445 – 456. 107 Keen H. The genetics of diabetes. from nightmare to headache. Br Med J 1987: 294: 917 – 919. 108 Kelly CG, Booth V, Kendal H, Slaney JM, Curtis MA, Lehner T. The relationship between colonization and haemagglutination inhibiting and B cell epitopes of Porphyromonas gingivalis. Clin Exp Immunol 1997: 110: 285 – 291. 109 Kelly JE, Van Kirk LE. Periodontal Disease in Adults, United States 1960–62, Vital and Health Statistics. PHS Publications, no. 1000, Series 11, no. 12. Washington, DC: U.S. Government Printing Office 1965. 110 Killian M. Degradation of immunoglobulin A1, A2 and G by suspected principal periodontal pathogens. Infect Immun 1981: 34: 757 – 764. 111 Kinane DF. Periodontitis modified by systemic factors. Ann Periodontol 1999: 4: 54 – 64. 112 Kinane DF, Adonogianaki E, Moughal N, Winstanley FP, Mooney J, Thornhill M. Immunocytochemical characterization of cellular infiltrate, related endothelial changes and determination of GCF acute-phase proteins during human experimental gingivitis. J Periodontal Res 1991: 26: 286 – 288. 113 Kinane DF, Karin SN, Garioch JJ, Al Badri AT, Moughal N, Goudie RB. Heterogeneity and selective localization of T cell clones in human skin and gingival mucosa. J Periodontal Res 1993: 28: 497 – 499. 114 Kinane DF, Mooney J, MacFarlane TW, McDonald M. Local and systemic antibody response to putative periodontpathogens in patients with chronic periodontitis: correlation with clinical indices. Oral Microbiol Immunol 1993: 8: 65 – 68. 115 Kinane DF, Takahashi K, Mooney J. Crevicular fluid and serum IgG subclasses and corresponding mRNA expressing plasma cells in periodontitis lesions. J Periodontal Res 1997: 32: 176 – 178. 116 Kjeldsen M, Holmstrup P, Bendtzen K. Marginal periodontitis and cytokines: a review of the literature. J Periodontol 1993: 64: 1013 – 1022. 117 Koj A. Initiation of acute phase response and synthesis of cytokines. Biochim Biophys Acta 1996: 1317: 84 – 94. 118 Kono Y, Ogawa T, Beagley KW, Fujihashi K, McGhee ML, McGhee JR, Hamada S, Kiyono H. Immunopathology of periodontal disease: studies with interleukins which mediate both immunoglobulin synthesis and inflammation in disease gingiva. In: S Hamada, SC Holt, JR McGhee, editors. Periodontal Disease Pathogens and Host Immune Responses. Tokyo: Quintessence Publishing Co., 1991: 209 – 221. 119 Kweider M, Lowe G, Murray G, Kinane D, McGowan D. Dental diseae, fibrinogen and white cell count: Links with myocardial infarction? Scott Med J 1993: 38: 73 – 74. 120 Lally ET, Baehni PC, McArthur WP. Local immunoglobulin synthesis in periodontal disease. J Periodontal Res 1980: 15: 159 – 164. 121 Lamster IB, Novak MJ. Host mediators in gingival crevicular fluid. Implications for the pathogenesis of periodontal disease. Crit Rev Oral Biol Med 1992: 3: 31 – 60. 122 Lamster IB, Oshrain RL, Celenti RS, Fine JB, Grbic JT. Indicators of the acute inflammatory and humoral immune responses in gingival crevicular fluid: relationship to active periodontal disease. J Periodontal Res 1991: 26: 261 – 263. 123 Lamster IB, Smith QT, Celenti RS, Singer RE, Grbic JT. Development of a risk profile for periodontal disease: microbial and host response factors. J Periodontol 1994: 65: 511 – 520. 124 Lang NP. Clinical markers of active periodontal disease. In: NW Johnson, editor. Periodontal Diseases: Markers of Disease Susceptibility and Activity. Cambridge: Cambridge University Press, 1991: 179 – 202. 125 Lang NP, Tonetti MS, Suter J, Sorrell J, Duff GW, Kornman KS. Effect of interleukin-1 gene polymorphisms on gingival inflammation assessed by bleeding on probing in a periodontal maintenance population. J Periodontal Res 2000: 35: 102 – 107. 126 Le J, Vilcek J. Interleukin 6: a multifunctional cytokine regulating immune reactions and the acute phase protein response. Lab Invest 1989: 6: 588 – 602. 127 Lehner T. Generation and assembly of secretory antibodies in plants. Science 1995: 268: 658 – 660. 128 Lilienfeld AM. Foundations of Epidemiology. New York: Oxford University Press, 1976: 255 – 262. 129 Ling TY, Sims TJ, Chen HA, Whitney CW, Moncla BJ, Engel LD, Page RC. Titer and subclass distribution of serum IgG antibody reactive with Actinobacillus actinomycetemcomitans in localized juvenile periodontitis. J Clin Immunol 1993: 13: 101 – 112. 130 Liu L, MacPherson GG. Dendritic cells 'in vivo': Their role in the initiation of intestinal immune responses. In: J Mestecky, MW Russell, S Jackson, SM Michalek, H Tlaskalová-Hogenová, S Šterzl, editors. Advances in Mucosal Immunology, Vol. 371A. New York: Plenum Press, 1995: 271 – 274. 131 Loesche WJ. Periodontal disease as a risk factor for heart disease. Compend Contin Educ Dent 1994: 15: 976 – 991. 132 Lopatin DE, Blackburn E. Avidity and titer of immunoglobulin G subclasses to Porphyromonas gingivalis in adult periodontitis patients. Oral Microbiol Immunol 1992: 7: 332 – 337. 133 Lopez NJ, Smith PC, Gutierrez J. Higher risk of preterm birth and low birth weight in women with periodontal disease. J Dent Res 2002: 81: 58 – 63. 134 Lowe GD. The relationship between infection, inflammation, and cardiovascular disease: an overview. Ann Periodontol 2001: 6: 1 – 8. 135 Lundqvist C, Hammarström M-L. T-cell receptor γδ-expressing intraepithelial lymphocytes are present in normal and chronically inflamed human gingiva. Immunology 1993: 19: 38 – 45. 136 Lundqvist CA, Taubman MA, Stoufi ED, Smith DJ,
Referência(s)